RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs 01-05-2019 - 30-04-2025 Show more information Organisation MITOLOGICS
RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors 01-05-2019 - 30-04-2027 Show more information Organisation MITOLOGICS